Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.
暂无分享,去创建一个
Luc Taillandier | Johan Pallud | Laurent Capelle | Emmanuel Mandonnet | Hugues Duffau | Jacques Guyotat | Rémy Guillevin | Luc Bauchet | Denys Fontaine | R. Guillevin | H. Duffau | E. Mandonnet | L. Capelle | K. Mokhtari | D. Fontaine | P. Peruzzi | J. Pallud | F. Laigle-Donadey | L. Taillandier | L. Bauchet | Karima Mokhtari | M. Baron | Philippe Peruzzi | Florence Laigle-Donadey | M. Kujas | J. Guyotat | Michèle Kujas | Marie-Hélène Baron
[1] J H Philippon,et al. Supratentorial low-grade astrocytomas in adults. , 1993, Neurosurgery.
[2] E R Laws,et al. Dysembryoplastic neuroepithelial tumor : a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases , 1988 .
[3] M. Faist,et al. Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults , 2006, Cancer.
[4] Pascale Varlet,et al. Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria , 1997, Journal of Neuro-Oncology.
[5] B. Fisher,et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] H. Schlemmer,et al. Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors. , 2003, International journal of radiation oncology, biology, physics.
[7] Michael H Lev,et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. , 2004, AJNR. American journal of neuroradiology.
[8] W. Huk,et al. Supratentorial Low-Grade Glioma: Results and Prognostic Factors Following Postoperative Radiotherapy , 1999, Strahlentherapie und Onkologie.
[9] J. Rock,et al. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. , 1998, Journal of neurosurgery.
[10] S. Coca,et al. Prognostic significance of tumor‐enhancement and angiogenesis in oligodendroglioma , 2002, Acta neurologica Scandinavica.
[11] H. Kauczor,et al. The role of MRI in patients with astrocytoma WHO II treated with fractionated stereotactic radiotherapy , 2004, European Radiology.
[12] M. Gilbert,et al. Diffusely infiltrative low-grade gliomas in adults. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] K. Skullerud,et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Michael A. Finn,et al. Transient postictal MRI changes in patients with brain tumors may mimic disease progression. , 2007, Surgical neurology.
[15] S. Grand,et al. IRM des oligodendrogliomes , 2005 .
[16] Laurent Capelle,et al. Continuous growth of mean tumor diameter in a subset of grade II gliomas , 2003, Annals of neurology.
[17] C. Daumas-Duport,et al. Classification des oligodendrogliomes de l’hôpital sainte-anne: Mise au point à l’usage des études retrospectives , 2005 .
[18] H. Duffau. Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity , 2005, The Lancet Neurology.
[19] A. Twijnstra,et al. Supratentorial grade II astrocytoma: biological features and clinical course , 2003, The Lancet Neurology.
[20] A. Bricolo,et al. Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients. , 1995, Surgical neurology.
[21] B. Devaux,et al. Glioma dissemination along the corticospinal tract , 2005, Journal of Neuro-Oncology.
[22] C. Daumas-Duport,et al. Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases , 1997, Journal of Neuro-Oncology.
[23] P. Warnke,et al. Correlation of Molecular Genetics with Molecular and Morphological Imaging in Gliomas with an Oligodendroglial Component , 2004, Clinical Cancer Research.
[24] Raymond Sawaya,et al. Prognostic significance of preoperative MRI scans in glioblastoma multiforme , 2004, Journal of Neuro-Oncology.
[25] Laurent Capelle,et al. Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns , 2006, Journal of Neuro-Oncology.
[26] David Schiff,et al. Low-grade gliomas: an update on pathology and therapy , 2005, The Lancet Neurology.
[27] D. Troost,et al. 5-Year survival and clinical prognostic factors in progressive supratentorial diffuse “low-grade” astrocytoma: A retrospective analysis of 46 cases , 2005, Acta Neurochirurgica.
[28] C. Daumas-Duport,et al. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies]. , 2005, Neuro-Chirurgie.
[29] A. Karim,et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] B. Fisher,et al. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. , 1999, International journal of radiation oncology, biology, physics.
[31] Webster K. Cavenee,et al. Pathology and genetics of tumours of the nervous system. , 2000 .
[32] A. Ramaioli,et al. Long-term outcome of oligodendrogliomas , 2004, Neurology.
[33] R. Makuch,et al. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. , 1996, Neurosurgery.
[34] Luc Taillandier,et al. Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas , 2006, Annals of neurology.
[35] B. Devaux,et al. Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. , 2001, Journal of neuroradiology. Journal de neuroradiologie.
[36] D. Kondziolka,et al. Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. , 1995, Journal of neurosurgery.
[37] K. Skullerud,et al. Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma , 1998, Journal of Neuro-Oncology.
[38] P. Kelly,et al. Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an Adjunct to Histopathology: A Second Reference Standard in the Surgical and Nonsurgical Treatment of Low-grade Gliomas , 2006, Neurosurgery.